Health IT

Healthcare Triangle secures $3.6M in complex convertible debt to fuel its AI ambitions. We unpack the high-stakes financing and what it means for the future.

EXL's new Gold Tier status with Databricks isn't just a partnership upgrade; it's a strategic move to solve AI's biggest business problem: data governance.

A Solana memecoin raised nearly $100k for breast cancer prevention, revealing a potentially resilient new model for creating sustainable social impact.

Echo IQ partners with Mayo Clinic to test its AI for cardiac risk in cancer patients, a key move for validation in the burgeoning cardio-oncology sector.

MBX Biosciences' new one-year data for canvuparatide isn't just a clinical win; it's a calculated move to dominate a billion-dollar market left vacant.

With its new Series A, Aton Health isn't just growing; it's validating a model where research is seamlessly integrated into routine patient care.

With a new CMO, Get A Drip is capitalizing on the longevity trend. But as it expands, it faces questions on scientific rigor and regulatory oversight.

A new survey shows Asians value independence over inheritance, yet a massive gap between intention and action threatens to derail their plans for self-reliance.

Elixiron's enrupatinib shows promise in targeting neuroinflammation, with early data suggesting cognitive benefits and a new biomarker-guided path for therapy.

While firms spend billions on tech, a new book argues the biggest data breaches stem from leadership gaps and process failures. Is your boardroom the real front line?

As hospitals face a ballooning $55B annual IT bill, Vizient's latest acquisition signals a major offensive to control costs beyond the traditional supply chain.

A new FDA-designated device aims to filter a deadly protein from the blood of sepsis patients. Can this novel approach finally conquer a global health crisis?

With a $20M Series A led by L Catterton, Dr. Muneeb Shah's REMEDY is disrupting skincare. Here's how accessible science is winning over consumers.

Xeris Biopharma secures a new patent for its rare disease drug KEVEYIS until 2039, a strategic move to fend off generic competition and lock in revenue.

As youth nicotine pouch use soars, Imperial Tobacco Canada calls for a crackdown on illicit sales. But is this a genuine public health plea or a masterful play to secure its market?

Leveraged finance titans turned a personal fight into a philanthropic powerhouse, raising a record $4.3M to fund the science that’s turning the tide on melanoma.

As Ontario doctors adopt AI to fight burnout, a new training program from OntarioMD tackles the urgent medico-legal and privacy risks head-on.

With over 55,000 on waitlists for the UK's first oral weight-loss pill, the market is set to explode. But strict rules and high hopes face a reality check.

With its $30M purchase of CareSeed, Sagility is betting on AI-driven analytics to move beyond compliance and redefine healthcare quality and financial outcomes.

Wellness brands often struggle to turn concepts into viable products. A Utah-based CDMO's new PhD-led center is bridging the gap from science to scale.